Insider · CIK 0001838047

Uger Robert

Reports to the SEC for 1 company · MISSISSAUGA, A6

sec.gov

Transactions

Companies

Filings

CIK

0001838047

Forms 4 and 5

Insider transactions

44 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−102K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−58.3K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−5,260 sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−23.5K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−29.1K sh	—	—	0
2021-11-17	Trillium Therapeutics Inc.Stock Option (Right to Buy)D Disposition to Issuer	Chief Scientific Officer	DDisposition to Issuer	−250K sh	—	—	0
2021-07-07	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,646 sh	$0.30	+$1,108.019	3,646
2021-07-07	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−3,646 sh	$9.00	−$32.8K	0
2021-07-07	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,646 sh	—	—	102,083
2021-06-07	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,646 sh	$0.32	+$1,148.49	3,646
2021-06-07	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−3,646 sh	$8.27	−$30.2K	0
2021-06-07	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,646 sh	—	—	105,729
2021-05-07	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,646 sh	$0.31	+$1,141.198	3,646
2021-05-07	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−3,646 sh	$9.30	−$33.9K	0
2021-05-07	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,646 sh	—	—	109,375
2021-04-07	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,646 sh	$0.30	+$1,098.175	3,646
2021-04-07	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−3,646 sh	$10.82	−$39.4K	0
2021-04-07	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,646 sh	—	—	113,021
2021-03-12	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,917 sh	$3.39	+$9,895.631	2,917
2021-03-12	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−2,917 sh	$11.97	−$34.9K	0
2021-03-12	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,917 sh	—	—	58,333
2021-03-08	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,646 sh	$0.30	+$1,093.435	3,646
2021-03-08	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−3,646 sh	$10.11	−$36.9K	0
2021-03-08	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,646 sh	—	—	116,667
2021-02-09	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+584 sh	$9.62	+$5,618.839	584
2021-02-09	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−584 sh	$14.12	−$8,248.416	0
2021-02-09	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−584 sh	—	—	5,260
2021-02-08	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,646 sh	$0.30	+$1,085.414	3,646
2021-02-08	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,917 sh	$3.31	+$9,666.063	6,563
2021-02-08	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−6,563 sh	$12.65	−$83K	0
2021-02-08	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,646 sh	—	—	120,313
2021-02-08	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,917 sh	—	—	61,250
2021-01-11	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+584 sh	$9.57	+$5,587.186	584
2021-01-11	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−584 sh	$15.20	−$8,878.669	0
2021-01-11	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−584 sh	—	—	5,844
2021-01-08	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+5,600 sh	$11.01	+$61.6K	5,600
2021-01-08	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−5,600 sh	$15.82	−$88.6K	0
2021-01-08	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+2,917 sh	$3.33	+$9,716.527	2,917
2021-01-08	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−2,917 sh	$15.51	−$45.2K	0
2021-01-08	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−5,600 sh	—	—	23,473
2021-01-08	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−2,917 sh	—	—	64,167
2021-01-07	Trillium Therapeutics Inc.M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	+3,646 sh	$0.30	+$1,089.06	3,646
2021-01-07	Trillium Therapeutics Inc.S Sale	Chief Scientific Officer	SSale	−3,646 sh	$14.75	−$53.8K	0
2021-01-07	Trillium Therapeutics Inc.Stock Option (Right to Buy)M Exercise/Conversion	Chief Scientific Officer	MExercise/Conversion	−3,646 sh	—	—	123,959

Recent filings

Accepted (ET)
Nov 194
Uger Robert0001104659-21-141739
SEC(opens sec.gov)
Jul 94
Uger Robert0001062993-21-006419
SEC(opens sec.gov)
Jun 94
Uger Robert0001062993-21-005487
SEC(opens sec.gov)
May 114
Uger Robert0001062993-21-004390
SEC(opens sec.gov)
Apr 94
Uger Robert0001062993-21-003543
SEC(opens sec.gov)
Mar 154
Uger Robert0001062993-21-002721
SEC(opens sec.gov)

Companies

Trillium Therapeutics Inc.Chief Scientific Officer

Address

C/O TRILLIUM THERAPEUTICS INC. 2488 DUNWIN DRIVE

MISSISSAUGA, A6, L5L 1J9